People
Peter Emtage
Peter Emtage is Versant Ventures’ current Venture Partner. Drug-development executive with prior cell-therapy and immunology leadership; Guelph molecular-biology education and McMaster doctorate, followed by National Cancer Institute research.
Roles
Versant Ventures
CurrentVenture Partner